Skip Navigation



JAC Advance Access published online on November 16, 2004
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkh474
© 2004 by The British Society for Antimicrobial Chemotherapy
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
54/6/971    most recent
dkh474v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Elliott, T. S. J.
Right arrow Articles by Sandoe, J. A. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elliott, T. S. J.
Right arrow Articles by Sandoe, J. A. T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Review

Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy

T. S. J. Elliott 1, J. Foweraker 2, F. K. Gould 3*, J. D. Perry 3, and J. A. T. Sandoe 4

1 Department of Microbiology, Queen Elizabeth Hospital, Birmingham, UK
2 Department of Microbiology, Papworth Hospital, Cambridge, UK
3 Department of Microbiology, Freeman Hospital, Newcastle-upon-Tyne, UK
4 Department of Medical Microbiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK

* To whom correspondence should be addressed.
F. K. Gould, E-mail: kate.gould{at}tfh.nuth.northy.nhs.uk


  Abstract

The BSAC Guidelines on Endocarditis were last published in 1998. The Guidelines presented here have been updated and extended to reflect changes in both the antibiotic resistance characteristics of causative organisms and the availability of new antibiotics. Randomized, controlled trials suitable for the development of evidenced-based guidelines in this area are still lacking, and therefore a consensus approach has again been adopted. The Guidelines cover diagnosis and laboratory testing, suitable antibiotic regimens and causative organisms. Special emphasis is placed on common causes of endocarditis, such as streptococci and staphylococci, however, other bacterial causes (such as enterococci, HACEK organisms, Coxiella and Bartonella) and fungi are considered. The special circumstances of prosthetic endocarditis are discussed.

Keywords: antibiotic therapy; guidelines; endocarditis; BSAC.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
L. Leibovici, L. Vidal, and M. Paul
Aminoglycoside drugs in clinical practice: an evidence-based approach
J. Antimicrob. Chemother., November 19, 2008; (2008) dkn469v1.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
D. F. J. Brown, R. Hope, D. M. Livermore, G. Brick, K. Broughton, R. C. George, R. Reynolds, and on behalf of the BSAC Working Parties on Resistanc
Non-susceptibility trends among enterococci and non-pneumococcal streptococci from bacteraemias in the UK and Ireland, 2001-06
J. Antimicrob. Chemother., November 1, 2008; 62(suppl_2): ii75 - ii85.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
D. M. Livermore
Future directions with daptomycin
J. Antimicrob. Chemother., November 1, 2008; 62(suppl_3): iii41 - iii49.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
J. M. Andrews and for the BSAC Working Party on Susceptibility Testi
BSAC standardized disc susceptibility testing method (version 7)
J. Antimicrob. Chemother., August 1, 2008; 62(2): 256 - 278.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
K. O. Helgason, A. H. Thomson, and C. Ferguson
A review of vancomycin therapeutic drug monitoring recommendations in Scotland
J. Antimicrob. Chemother., June 1, 2008; 61(6): 1398 - 1399.
[Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
B. C. Millar, B. D. Prendergast, and J. E. Moore
Community-associated MRSA (CA-MRSA): an emerging pathogen in infective endocarditis
J. Antimicrob. Chemother., January 1, 2008; 61(1): 1 - 7.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
D. Yung, D. Kottachchi, B. Neupane, S. Haider, and M. Loeb
Antimicrobials for right-sided endocarditis in intravenous drug users: a systematic review
J. Antimicrob. Chemother., November 1, 2007; 60(5): 921 - 928.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
J. M. Andrews and for the BSAC Working Party on Susceptibility Testi
BSAC standardized disc susceptibility testing method (version 6)
J. Antimicrob. Chemother., July 1, 2007; 60(1): 20 - 41.
[Full Text] [PDF]

Home page
 BMJHome page
R. P Beynon, V K Bahl, and B. D Prendergast
Infective endocarditis
BMJ, August 12, 2006; 333(7563): 334 - 339.
[Full Text] [PDF]

Home page
 HeartHome page
B D Prendergast
The changing face of infective endocarditis
Heart, July 1, 2006; 92(7): 879 - 885.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
D. W. M. Verhagen, A. C. Vedder, P. Speelman, and J. T. M. van der Meer
Antimicrobial treatment of infective endocarditis caused by viridans streptococci highly susceptible to penicillin: historic overview and future considerations
J. Antimicrob. Chemother., May 1, 2006; 57(5): 819 - 824.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
C. G. Gemmell, D. I. Edwards, A. P. Fraise, F. K. Gould, G. L. Ridgway, R. E. Warren, and on behalf of the Joint Working Party of the Britis
Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK
J. Antimicrob. Chemother., April 1, 2006; 57(4): 589 - 608.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
P. M. Shah
Comment on: Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy
J. Antimicrob. Chemother., August 1, 2005; 56(2): 432 - 432.
[Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
J. D. Perry and on behalf of the Working Party of the British Soci
Endocarditis guidelines: authors' response
J. Antimicrob. Chemother., August 1, 2005; 56(2): 432 - 433.
[Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.